BiotechTube
Home/NovalGen/Professor Amit Nathwani
PA

Professor Amit Nathwani

Chief Executive Officer

NovalGen

Therapeutic Areas

OncologyAutoimmuneHaematologicalMetabolic

NovalGen Pipeline

DrugIndicationPhase
NVG-222Not Specified (Oncology/Haematological)Phase 1
Lead Self-Regulating ImmunotherapyNot SpecifiedPre-clinical/Phase 1

Leadership Team at NovalGen

BT
Bharat Thakrar
Chairman
DD
Dr. David Granger
VP R&D
View full NovalGen profile